Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 18, 2026 Off

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

By GlobeNewswire

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company…

February 17, 2026 Off

Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

By GlobeNewswire

Management will participate in three upcoming investor healthcare conferencesSALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) — Myriad Genetics, Inc.…

February 17, 2026 Off

Galapagos Receives Transparency Notification from Bank of America

By GlobeNewswire

Mechelen, Belgium; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification…

February 17, 2026 Off

Betterbrand Founder Turns Family Tragedy Into Clinically-Studied Lung Support

By GlobeNewswire

Army medic–turned–PharmD launches BetterLungs™ after losing relatives to smoking-related respiratory illnessSAN ANTONIO, Feb. 16, 2026 (GLOBE NEWSWIRE) — Betterbrand, a…

February 16, 2026 Off

Sapu Bioscience Expands International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway

By GlobeNewswire

SAN DIEGO, CA, Feb. 16, 2026 (GLOBE NEWSWIRE) — Sapu Bioscience today announced advancements in its global IP portfolio supporting…

February 14, 2026 Off

BioRestorative Announces Closing of $5.0 Million Public Offering

By GlobeNewswire

MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage…

February 14, 2026 Off

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway

By GlobeNewswire

The Put Option Agreement positions Psyence BioMed for potential significant future equity participation in one of the world’s most advanced…

February 14, 2026 Off

Ocular Therapeutix™ to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026

By GlobeNewswire

Ocular to host webcast scheduled for Tuesday, February 17, 2026, at 8:00 AM ET Detailed SOL-1 data to be presented…

February 14, 2026 Off

Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

By GlobeNewswire

Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron Mr. Willard has a 30+…

February 14, 2026 Off

Inotiv Provides Notice Regarding Cybersecurity Incident

By GlobeNewswire

WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract…

Posts pagination

Previous 1 … 3 4 5 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine